Carvalho, Adriana Camargo <br/><br/>
Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.  [electronic resource] 

 -  PloS one  2017 
 - e0175409 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0175409  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--economics<br/>Antineoplastic Agents--economics<br/>Cetuximab--economics<br/>Colorectal Neoplasms--drug therapy<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Panitumumab<br/>Treatment Outcome